Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.37/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.37), versus ($0.51) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Restoration Hardware (RH) PT Raised to $130 at Stifel After Q1 Earnings
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c